BASEL, Switzerland, Sept. 10 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles on the following topics in its October 2022 edition:

Review Articles:

* Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials

* The nuclear transportation of PD-L1 and the function in tumor immunity and progression